Analyze Diet
Drug testing and analysis2014; 7(1); 21-30; doi: 10.1002/dta.1719

Controlling the misuse of cobalt in horses.

Abstract: Cobalt is a well-established inducer of hypoxia-like responses, which can cause gene modulation at the hypoxia inducible factor pathway to induce erythropoietin transcription. Cobalt salts are orally active, inexpensive, and easily accessible. It is an attractive blood doping agent for enhancing aerobic performance. Indeed, recent intelligence and investigations have confirmed cobalt was being abused in equine sports. In this paper, population surveys of total cobalt in raceday samples were conducted using inductively coupled plasma mass spectrometry (ICP-MS). Urinary threshold of 75 ng/mL and plasma threshold of 2 ng/mL could be proposed for the control of cobalt misuse in raceday or in-competition samples. Results from administration trials with cobalt-containing supplements showed that common supplements could elevate urinary and plasma cobalt levels above the proposed thresholds within 24 h of administration. It would therefore be necessary to ban the use of cobalt-containing supplements on raceday as well as on the day before racing in order to implement and enforce the proposed thresholds. Since the abuse with huge quantities of cobalt salts can be done during training while the use of legitimate cobalt-containing supplements are also allowed, different urinary and plasma cobalt thresholds would be required to control cobalt abuse in non-raceday or out-of-competition samples. This could be achieved by setting the thresholds above the maximum urinary and plasma cobalt concentrations observed or anticipated from the normal use of legitimate cobalt-containing supplements. Urinary threshold of 2000 ng/mL and plasma threshold of 10 ng/mL were thus proposed for the control of cobalt abuse in non-raceday or out-of-competition samples.
Publication Date: 2014-09-25 PubMed ID: 25256240DOI: 10.1002/dta.1719Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Validation Study

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates the misuse of cobalt as a performance enhancing substance in equine sports. The study proposes certain thresholds for cobalt levels in a horse’s system in different contexts (race day versus non-race day), and recommends the banning of cobalt-containing supplements on race day and the day before.

Context and Methodology

  • The research revolves around the misuse of cobalt in horses, particularly in equine sports. Cobalt is known to trigger hypoxia-like effects in organisms, modulating certain genes to induce erythropoietin transcription, leading to increased red blood cell production and thus, enhanced aerobic performance.
  • The affordability and accessibility of cobalt salts, coupled with their oral activity, make them attractive for blood doping in sports, essentially enhancing an equine athlete’s stamina and performance.
  • The authors conducted surveys of cobalt levels in race day samples, using a technique called Inductively Coupled Plasma Mass Spectrometry (ICP-MS).

Findings

  • From their research, the scientists proposed certain thresholds to control cobalt misuse on raceday or in competition samples. These thresholds are set at a urinary track of 75 ng/mL and a plasma threshold of 2 ng/mL.
  • Investigations on the effects of cobalt-containing supplements revealed that the common supplements could increase urinary and plasma cobalt levels beyond the proposed thresholds within just 24 hours of administration. This is a significant finding as it shows how readily cobalt levels can be manipulated in the body, making doping easier.

Suggestions for Control

  • In light of their findings, the authors suggest banning the use of cobalt-containing supplements on raceday and the day before racing. This move is proposed as a way to enforce the suggested thresholds successfully.
  • Considering that misuse could occur during training periods as well as racedays, separate urinary and plasma cobalt thresholds are suggested in the context of non-racedays or out-of-competition samples.
  • To implement this, the recommended thresholds to control cobalt misuse are observed to be 2000 ng/mL for urinary and 10 ng/mL for plasma.
  • The thresholds were recommended based on normal use of legitimate cobalt-containing supplements, ensuring that proper use won’t be affected by these regulations.

Cite This Article

APA
Ho EN, Chan GH, Wan TS, Curl P, Riggs CM, Hurley MJ, Sykes D. (2014). Controlling the misuse of cobalt in horses. Drug Test Anal, 7(1), 21-30. https://doi.org/10.1002/dta.1719

Publication

ISSN: 1942-7611
NlmUniqueID: 101483449
Country: England
Language: English
Volume: 7
Issue: 1
Pages: 21-30

Researcher Affiliations

Ho, Emmie N M
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
Chan, George H M
    Wan, Terence S M
      Curl, Peter
        Riggs, Christopher M
          Hurley, Michael J
            Sykes, David

              MeSH Terms

              • Animals
              • Chromatography, Liquid / methods
              • Cobalt / blood
              • Cobalt / urine
              • Dietary Supplements / analysis
              • Doping in Sports
              • Horses / blood
              • Horses / urine
              • Limit of Detection
              • Substance Abuse Detection / methods
              • Tandem Mass Spectrometry / methods

              Citations

              This article has been cited 7 times.
              1. LeCompte Lazić RA, Nielsen BD, Robison CI, Schott HC 2nd, Herdt TH, Larson CK. Influence of Dietary Cobalt on Fiber Digestibility and Serum Cobalt and Cobalamin Concentrations in Horses. Animals (Basel) 2024 Dec 12;14(24).
                doi: 10.3390/ani14243595pubmed: 39765500google scholar: lookup
              2. García Á, Toro-Román V, Siquier-Coll J, Bartolomé I, Muñoz D, Maynar-Mariño M. Effects of Tetraselmis chuii Microalgae Supplementation on Anthropometric, Hormonal and Hematological Parameters in Healthy Young Men: A Double-Blind Study. Int J Environ Res Public Health 2022 May 16;19(10).
                doi: 10.3390/ijerph19106060pubmed: 35627597google scholar: lookup
              3. Skalny AV, Zaitseva IP, Gluhcheva YG, Skalny AA, Achkasov EE, Skalnaya MG, Tinkov AA. Cobalt in athletes: hypoxia and doping - new crossroads. J Appl Biomed 2019 Mar;17(1):28.
                doi: 10.32725/jab.2018.003pubmed: 34907754google scholar: lookup
              4. Fazio F, Gugliandolo E, Nava V, Piccione G, Giannetto C, Licata P. Bioaccumulation of Mineral Elements in Different Biological Substrates of Athletic Horse from Messina, Italy. Animals (Basel) 2020 Oct 14;10(10).
                doi: 10.3390/ani10101877pubmed: 33066668google scholar: lookup
              5. Ueda T, Tozaki T, Nozawa S, Kinoshita K, Gawahara H. Identification of metabolomic changes in horse plasma after racing by liquid chromatography-high resolution mass spectrometry as a strategy for doping testing. J Equine Sci 2019 Sep;30(3):55-61.
                doi: 10.1294/jes.30.55pubmed: 31592223google scholar: lookup
              6. Burns TA, Dembek KA, Kamr A, Dooley SB, Dunbar LK, Aarnes TK, Bednarski LS, O'Brien C, Lakritz J, Byrum B, Wade A, Farmer R, Tan S, Toribio RE. Effect of Intravenous Administration of Cobalt Chloride to Horses on Clinical and Hemodynamic Variables. J Vet Intern Med 2018 Jan;32(1):441-449.
                doi: 10.1111/jvim.15029pubmed: 29286554google scholar: lookup
              7. Plumb JO, Otto JM, Grocott MP. 'Blood doping' from Armstrong to prehabilitation: manipulation of blood to improve performance in athletes and physiological reserve in patients. Extrem Physiol Med 2016;5:5.
                doi: 10.1186/s13728-016-0046-0pubmed: 26929820google scholar: lookup